Cáncer de mama precoz: el caso de la neoadyuvancia en HER2 positivo - page 13

NOAH: trastuzumab improves pCR rates in
patients with HER2-positive LABC
50
40
30
20
10
0
With H Without H HER2 negative
Patients with pCR (%)
HER2 positive
43
23
17
p=0.29
p=0.002
Gianni, et al. Lancet 2010 pCR = pathological CR